GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » Equity Investments

Dali Pharmaceutical Co (SHSE:603963) Equity Investments


View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co Equity Investments?

Equity Investments only applies to insurance companies.


Dali Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000
Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.
Executives
Wu Pei Rong senior management
Yang Jun Xiang Directors, senior managers
Yang Jun Wei Director